Text adapted from "The patient with Psychosis" in Psychiatry in primary care by George Foussias and Z. Jeff Daskalakis (CAMH, 2019).
Addington, D., Abidi, S., Garcia-Ortega, I., Honer, W. & Ismail, Z. (2017). Canadian guidelines for the assessment and diagnosis of patients with schizophrenia spectrum and other psychotic disorders. Canadian Journal of Psychiatry, 62, 594–604.
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
Canadian Pharmacists Association. (2019). Compendium of Pharmaceuticals and Specialties. Ottawa, ON: Author.
Norman, R., Lecomte, T., Addington, D. & Anderson, E. (2017). Canadian treatment guidelines on psychosocial treatment of schizophrenia in adults. Canadian Journal of Psychiatry, 62, 617–623.
Pringsheim, T., Kelly, M., Urness, D., Teehan, M., Ismail, Z. & Gardner, D. (2017). Physical health and drug safety in individuals with schizophrenia. Canadian Journal of Psychiatry, 62, 673–683.
Procyshyn, R.M., Bezchlibnyk-Butler, K.Z. & Jeffries, J. (2017). Clinical Handbook of Psychotropic Drugs (22nd ed.). Boston, MA: Hogrefe.
Remington, G., Addington, D., Honer, W., Ismail, Z., Raedler, T. & Teehan, M. (2017). Guidelines for the pharmacotherapy of schizophrenia in adults. Canadian Journal of Psychiatry, 62, 604–616.
About the Authors
George Foussias, MD, PhD, FRCPC Assistant professor, Department of Psychiatry, University of Toronto; associate chief, Schizophrenia Division, and medical head, Slaight Family Centre for Youth in Transition, Centre for Addiction and Mental Health, Toronto, ON
Z. Jeff Daskalakis, MD, PhD, FRCPC Professor, Department of Psychiatry, University of Toronto; chief, General Adult Psychiatry and Health Systems Division, and Temerty Chair in Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON